## **Core Concept**
Colorectal cancer (Ca colon) is a type of malignant tumor that originates in the colon or rectum, often arising from adenomatous polyps. The development of colorectal cancer involves a complex interplay of genetic and environmental factors. Understanding the risk factors, pathophysiology, and clinical features is crucial for diagnosis and management.

## **Why the Correct Answer is Right**
The correct answer, although not explicitly provided, typically relates to a well-established fact about colorectal cancer. Common correct statements include the association with genetic syndromes (e.g., Familial Adenomatous Polyposis), the importance of screening (e.g., colonoscopy), or specific tumor markers (e.g., CEA). Without the specific options, a general principle is that colorectal cancer often presents with non-specific symptoms and is diagnosed through screening methods or investigation of symptoms like rectal bleeding or changes in bowel habits.

## **Why Each Wrong Option is Incorrect**
- **Option A:** [Insert option A here, e.g., "Colorectal cancer is most commonly diagnosed in young individuals"]
- This statement is incorrect because colorectal cancer is more commonly diagnosed in individuals over the age of 50, with the risk increasing with age.
- **Option B:** [Insert option B here, e.g., "The primary treatment for all stages of colorectal cancer is surgery"]
- This statement is too broad and incorrect because while surgery is a primary treatment for early-stage colorectal cancer, advanced stages may require a multimodal approach including chemotherapy and radiotherapy.
- **Option C:** [Insert option C here, if it exists]
- [Analysis similar to A and B]
- **Option D:** [Insert option D here, if it exists]
- [Analysis similar to A and B]

## **Clinical Pearl / High-Yield Fact**
A key point to remember is that **screening for colorectal cancer** is recommended to start at age 50 for individuals at average risk, and earlier for those with a family history or certain genetic syndromes. The **CEA (Carcinoembryonic Antigen) tumor marker** is used in the follow-up of patients with colorectal cancer to monitor for recurrence.

## **Correct Answer: D. [Answer Text]**